发明名称 BENZIMIDAZOLE CYCLOOXYGENASE-2-INHIBITORS
摘要 This invention provides a compound of the following formula: (see fig. I) or the pharmaceutically acceptable salts thereof, preferably wherein Ar is heteroaryl; X1 and X2 are independently selected from halo, C1-C4 alky l, hydroxy, C1-C4 alkoxy, amino, C1-C4 alkanoyl, carboxy, carbamoyl, cyano, nitro, mercapto, (C1-C4 alkyl)thio, (C1-C4 alkyl)sulfinyl, (C1-C4 alkyl)sulfonyl, aminosulfonyl, or the like; R1 is selected from hydrogen, straight or branch ed C1-C4 alkyl, C3-C8 cycloalkyl, C4-C8 cycloalkenyl, phenyl , heteroaryl and the lik e; R2 and R3 are independently selected from hydrogen, halo, C1-C4 alkyl, phenyl and t he like; or R1 and R2 can form, together with the carbon atom to which they are attached, a C5-C7 cycloalkyl ring; and m and n are independently 0, 1, 2 or 3. These compounds and pharmaceutical compositions containing such compounds a re useful as analgesics and anti-inflammatory agents.
申请公布号 CA2261426(C) 申请公布日期 2002.09.24
申请号 CA19992261426 申请日期 1999.02.09
申请人 PFIZER INC. 发明人 MURATA, YOSHINORI;MANO, TAKASHI;OKUMURA, YOSHIYUKI
分类号 A61K31/00;A61K31/41;A61K31/425;A61K31/427;A61K31/44;A61K31/4427;A61K31/443;A61K31/4433;A61K31/4439;A61K31/495;A61K31/4965;A61K31/497;A61K31/505;A61K31/506;A61K31/53;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P13/00;A61P13/12;A61P19/00;A61P19/02;A61P19/10;A61P25/00;A61P25/04;A61P25/28;A61P29/00;A61P35/00;A61P43/00;C07D401/04;C07D401/14;C07D403/04;C07D405/14;C07D409/14;C07D413/14;C07D417/04;C07D417/14;(IPC1-7):C07D401/04 主分类号 A61K31/00
代理机构 代理人
主权项
地址